Lv1
45 积分 2021-02-22 加入
Evolving therapeutic landscape of advanced hepatocellular carcinoma
24天前
已完结
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
1个月前
已完结
Therapeutic RNA-silencing oligonucleotides in metabolic diseases
1个月前
已完结
Targeting the tumour stroma to improve cancer therapy
1个月前
已完结
Turning foes to friends: targeting cancer-associated fibroblasts
1个月前
已完结
Immuno-oncology clinical trials take a turn beyond PD1/PDL1 inhibitors
1个月前
已完结
Biopharma dealmaking in 2023
1个月前
已完结
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Molecular Engineering of Surface Functional Groups Enabling Clinical Translation of Nanoparticle–Drug Conjugates
1个月前
已完结
Stapled Liposomes Enhance Cross‐Priming of Radio‐Immunotherapy
1个月前
已完结
